High body mass index is associated with increased risk of treatment failure and surgery in biologic‐treated patients with ulcerative colitis
Alimentary Pharmacology & Therapeutics2018Vol. 47(11), pp. 1472–1479
Citations Over TimeTop 10% of 2018 papers
Soumya Kurnool, Nghia Nguyen, J. Proudfoot, Parambir S. Dulai, Brigid S. Boland, Niels Vande Casteele, Elisabeth Evans, Eduardo Grunvald, Amir Zarrinpar, William J. Sandborn, Siddharth Singh
Abstract
BMI is independently associated with increased risk of treatment failure in biologic-treated patients with UC, independent of dosing regimen.
Related Papers
- THE EXPERIMENTAL STUDY OF THE RELATED CYTOKINES FOR IN PATIENTS WITH ULCERATIVE COLITIS.(2005)
- Investigation of Serum NO Levels in Patients With Ulcerative Colitis(2002)
- Determination of plasma P-selection in patients with ulcerative colitis and their clinical significance(2004)
- The severity correlation of TNF-α,IL-6 and IL-8 levels in plasma in patients with ulcerative colitis and their clinical significances(2008)
- → To study on nutritional status in patients with ulcerative colitis(2023)